View : 30 Download: 0

INFLIXIMAB AS THE FIRST RETREATMENT IN PATIENTS WITH KAWASAKI DISEASE RESISTANT TO INITIAL INTRAVENOUS IMMUNOGLOBULIN

Title
INFLIXIMAB AS THE FIRST RETREATMENT IN PATIENTS WITH KAWASAKI DISEASE RESISTANT TO INITIAL INTRAVENOUS IMMUNOGLOBULIN
Authors
Youn, YoungminKim, JisooHong, Young MiSohn, Sejung
Ewha Authors
홍영미손세정
SCOPUS Author ID
홍영미scopus; 손세정scopus
Issue Date
2016
Journal Title
PEDIATRIC INFECTIOUS DISEASE JOURNAL
ISSN
0891-3668JCR Link1532-0987JCR Link
Citation
vol. 35, no. 4, pp. 457 - 459
Keywords
Kawasaki diseaseintravenous immunoglobulininfliximabretreatment
Publisher
LIPPINCOTT WILLIAMS & WILKINS
Indexed
SCI; SCIE; SCOPUS WOS scopus
Abstract
Forty-three patients with Kawasaki disease who were resistant to initial intravenous immunoglobulin (IVIG) were randomized to receive either a second dose of IVIG (n = 32) or an infliximab (n = 11). With IVIG retreatment 21 patients (65.6%) responded, and with infliximab 10 patients (90.9%) responded. The infliximab group had shorter duration of fever and fewer days of hospitalization. Coronary artery outcomes and adverse events were similar.
DOI
10.1097/INF.0000000000001039
Appears in Collections:
의학전문대학원 > 의학과 > Journal papers
Files in This Item:
There are no files associated with this item.
Export
RIS (EndNote)
XLS (Excel)
XML


qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

BROWSE